Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Fuji
McKinsey
Novartis
Citi
McKesson
Argus Health
Cipla
Deloitte

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050131

« Back to Dashboard

NDA 050131 describes BICILLIN L-A, which is a drug marketed by King Pharms Llc and Wyeth Ayerst and is included in two NDAs. It is available from two suppliers. Additional details are available on the BICILLIN L-A profile page.

The generic ingredient in BICILLIN L-A is penicillin g benzathine. There are eighty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the penicillin g benzathine profile page.
Summary for 050131
Tradename:BICILLIN L-A
Applicant:Wyeth Ayerst
Ingredient:penicillin g benzathine
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 050131

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength300,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Cerilliant
Johnson and Johnson
US Army
Dow
Chinese Patent Office
Cipla
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot